HG exam 21-30

Glycation 

- Glycation = _____non-enzymatic rxn_____________between reducing sugars and proteins/lipids/nucleic acids (macromolecules)

- Stiffness and loss of elasticity in arteries & organs

- Reduction of sugars causes accumulation of glycation end products in the extracellular matrix

- Protein molecules then crosslink sugar molecules = advanced glycation end products (AGEs)

- Body does not recognize as normal, makes antibodies to attack = ____inflammation__________

- Deposits into skin = ____wrinkling ______

Genetic technology: pcr & sequencing 

PCR - what goes in 

- Mimics what happens in your cells when they undergo DNA replication

- primers____ known sequence flanking area of interest

- ______DNA polymerase_________ enzyme required to add nucleotides to new strand

- template DNA________ what you want to amplify from

- ___nuceotides_________ to add on to the amplified strand

PCR thermocycler steps

- 1. Initial denaturation 

- 2. Denaturation 

- 3. Annealing 

- 4. Extension

- 5. Final extension 

- denaturation, annealing, and extension are repeated 30-40 cycles

PCR thermocycler steps 

1. Denaturation

- Typically, performed at 94°C

- Allows for full denaturation of the template strands, especially long DNA strands (breaks ____hydrogen bonds________ between strands)

- Will be repeated each of the 30 - 40 cycles

PCR thermocycler steps 

- 2. Annealing

- Typically, at 54°C

- Lower temperature allows primers to anneal__ to template

- Have 2 primers (forward & reverse) for each of the parent strands

- Will be repeated each of the 30-40 cycles

PCR thermocycler steps 

- 3. Extension

- Typically, at 72°C

- Optimal for DNA polymerase to bind to primer/template

- Adds free nucleotides______ to new strand

- Will be repeated each of the 30-40 cycles

PCR thermocycler steps 

- 5. Final Extension

- Typically at 72°C

- Makes sure all strands are completely finished

How to see your PCR 

- Gel electrophoresis

- DNA is negatively ________charged

- If you apply an electrical current it will migrate (from =  – to +)

- Use a chemical like ethidium bromide to visualize under UV

First Generation sequencing 

- Sanger Sequencing (Aka.....chain termination method or dideoxynucleotide method)

- Uses only one strand of the double stranded DNA

- Start synthesizes new DNA strand using primer

- Uses dideoxynucleotides (ddNTPs = ddG, ddA, ddC, ddT) & regular nucleotides

- When a ddNTP is incorporated, ___elognation stops___________

- Results in numerous fragments with ddNTP on end

- Separate fragments on gel, align sequence and read it

Sanger sequencing 

- How to read a Sanger Sequence

- Start at the top and work down the gel

- 1st use = 1977

- Used for decades, some still today

- Drawback = ___cost & time__________

Second generation sequencing 

- Called “sequence by synthesis”

- Benefits over 1st Generation Sequencing: 

- Millions of short reads in parallel

- Faster & low cost

- Don’t have to do gel electrophoresis

Second generation sequencing 

- Fragment DNA

- Run PCR to add adenosine_________ to ends that primers attach to

- Add to flow cell that has adapters

- Primers bind to adapters

- Amplified and bends to match next adapter

- Fluorescently labeled nucleotides bind during amplification

- This gives a color signal to record the base

Third generation sequencing 

- Called “single molecule real time read”

- Benefits over 1st Generation Sequencing

- 2 nd Generation requires an initial round of PCR first, 3rd Generation does not

- Complex genomes with lots of repeats confuse 2nd Generation, 3rd Generation does not

- 3rd Generation does not need chemical labeling 

Third generation sequencing 

- Nanopore

- _____single strand _____________DNA is fed thru a small pore opening (10-9 meters)

- Constant electrical field is generated

-Each nucleotide changes the current differently

Sequencing coming to a bedside near you 

- Illumina $30,000 sequencer = human genome 1 hour = $1000

- Establish in hospitals to:

- Avoid cost of drug/therapy that has little chance of success

- Avoid/limit patient side effects

- Decrease disease burden looking for right treatment

- Act in preventative manner by predicting susceptibility

- Making correct diagnosis

- Monitoring and typing infections

Genomics - human genome project 

- Goals (started 1990 by Watson, used WBC 2 males & 2 females, started 1990 & finished 2003) Publicly funded

- 1. ____identify_____ all human genes

- 2. ___map location_________ of all human genes

- 3. ____sequence________ all 24 chromosomes (looked at only euchromatin)

- 4. Analyze ___variation_______ between humans (ex. SNPs, VNTR)

- 5. Map & sequence genomes of _____model organisms _________ for future medical research

- 6. Develop new _____genetic technologies______________ to speed up research

- 7. Give findings to other scientists & ___general public__________

- 8. Set up ___ELSI__ program (Ethical -Legal- Social)

Genomics - human genome project 

- How to sequence a genome

- Step 1 : Cut the genome into ______small overlapping pieces_________________

- Step 2 : Determine the ____sequence________ of smaller pieces

- Step 3 : Use ____algorithms________ to find overlaps

- Step 4 : overlap________ pieces to determine sequences

- * However, using this method missed CNV__

Sanger Sequencing 

- Frederick Sanger, 1977

- Basically combines PCR___of unknown DNA segments and ___gel electropheresis_____________

- Uses _____fluorescently___labeled__________ dideoxynucleotides (lacks a ____3’ hydroxyl group ________)

Genomics - human genome project 

- Gov’t funded:

- _____clone by clone method__________________

- _____1 chromosome @ a time__________________

- ________slower_______________

- ________doesn’t miss repeats_______________

Celera Genomics (Craig Venter)

- ___whole genome shotgun____________________

-_____entire genome at once_________________

- ______faster_________________

- _______misses repeats_______________

Genomics - human genome project 

- The results:

- HG = 3.1 billion nucleotides

- Less than 2% of the HG is protein coding

- We are all 99.9% similar (SNP & CNV)

- Average size of a gene = 25kb

- 50% sequence similarity to other organisms

- Genes not uniformly distributed (Chromosome 1 most, Y chromosome least)

- Largest protein gene = Dystrophin (2.5Mb) (1Mb = 1,000,000 bp )

Genomics - human genome project 

- Cooler ways to sequence came from the HGP $3 billion & 10 years → $1000 & few hours

- Chain termination - Fluorescent labeling

- Nanomaterial

Genomics - proteomics 

- Proteomics is the identification, characterization, & quantitative analysis of the proteome of a cell, tissue or organism

- Which is larger: proteome or genome?

- Due to protein ____modification__________ & ______alternative splicing _____________

- Looks at :

- 1. Protein - protein interactions

- 2. Protein regulation

- 3. Protein modification

- 4. Protein location

- 5. Protein detection & quantization

- Methods

- 1. Isolate proteins from a _____single organelle__________________

- 2. Isolate entire protcome__________ Three areas of proteome analysis

- 1. ___expression__________ proteomics

- 2. ____bioinformatics___________ proteomics

- 3. ____functional___________ proteomics

Genomics - microbiome 

- Human Microbiome Project 2007 - 2012 ($115 million)

- Sequenced the bacterial___, fungi__, & viruses__ that make up the microbiome of 250 healthy adults

- Sampled 17 areas on body and sequenced the 16s rRNA________ of bacteria

- Goals

- 1. Do humans share a core________ human microbiome?-

- 2. Does the microbiome ____change with health____________________

- 3. _____develop new technology__________________ to analyze the microbiome

- 4. Address ___ELSI____________

Genomics - microbiome 

- Obtained 1000x more sequence data than the HGP

- 10,000 different bacterial species, 100 trillion

- Microbiome starts at birth

- We all have different microbiomes with similar groups

- More diverse = healthy

- Less diverse = unhealthy

- Smoking v pregnancy

- IBD & C. diff

- Twins

- Microbe fingerprint

Microbiome - brain/gut axis 

- Brain - gut axis

- 1.__lymphocytes___________ sense gut lumen, release cytokines

- 2. _____vagus nerve________ terminals activated by gut microbial peptides

- 3. ____neurotransmitters_______________ made in response to microbial metabolites

- 4. hormone______ release via hypothalamic pituitary, modulates gut composition

- 5.__neural activation______________– sympathetic activation produce neurotransmitters modify microbiota composition

- How do we study the BGA?

- 1. ___germ-free mice_____________ = mice born devoid of any normal bacterial flora

- 2. ___probiotic_____________ = Lactobacillus & Bifidobacterium reduce anxiety levels, lower inflammatory cytokines, reduced depression

- 3. _____antibiotic intervention___________________ = reduce biodiversity, delays re - colonization

- by probiotics, expression of GI symptoms

- 4. infection____ = increases inflammation, anxiety, Campylobacter pathogen activated brain regions associated with processing GI sensory information

Genomics - metagenomics 

- Metagenomics is also called ___environmental genomics______________ and uses the ____whole genome shotgun____________approach to sequence the genomes of entire communities of microbes in environmental samples of water, air, soil.

- Want to understand

- 1. ___interactions________ of microbial communities & environment

- 2. ___classify________ new species

- 3. Identify genes with novel functions__________ (medicine/biotech)

- 4. Be able to isolate DNA directly from ____sampled area___________

- The Sorcerer II Global Sampling Expedition (Craig Venter)

Genomics - other “omics” 

- ___metabolomics__________ : Study of proteins & enzymatic pathways in cell metabolism

- gkycomics__________ : Study of carbohydrates of cells or tissue

- ____toxicogenomics__________: Study of the effects of toxic chemicals on genes

- ___transcribtomics___________ : Study of all gene transcripts in tissue or cells

- _____stone age genomics____________: Study of ancient DNA (oldest 70,000)

- ___nutrigenomics______________ : Study of the interactions of diet and genes

Genomics - systems biology 

- Is an intergrative__________ process

- Interprets ____genomic information_________________ in the context of _____biological pathways___________

- ____interactome___________ is the

- 1. Protein to protein interactions

- 2. Protein to nucleic acid interactions

- 3. Protein to metabolite interactions

- ___network map___________ – shows interacting proteins, genes, & molecules, but cannot tell you when & where the interaction occurs

- Important for:

- 1. Scientists – model potential interactions in normal and disease processes

- 2. Pharmaceuticals – drug discovery, development, detection

Genomics - bioinformatics 

- Bioinformatics = the use of _____computers & mathematics _______________to organize, share, and analyze data related to gene and protein sequence____, structure, function & expression

- ____databases_______ are essential for the storage and sharing of all this newfound information

- gen bank____ is the largest publicly available database of DNA sequences (doubles in size every 14 months, 100,000 different species)

- BLAST will tell you

- 1. Genes with similar sequences

- 2. E - values = matching the sequence based on chance

- 3. Identities = similarity score based on alignment

- 4. Gaps = deletions or insertion points

Pharmacogenetics & personalized medicine 

The ACCE test 

- A = ___analytical_______________= how well does the test measure what it claims to measure (accuracy)

- C = ___clinical valibdation_____________= how well does the test predict the health outcome that it claims

- C = _____clinical utility__________= how useful are the results to the patient

- E = ____ethical aspects___________ = is it voluntary, insurance, employment

Pharmacy meets genomics 

- First step to personalized medicine = personalized prescribing

- Medicine has different effects on different patients

- Some patients have different sensitivities_______ = higher/lower dose

- Some individual patients have no__ therapeutic effect

- Some individual patients have ___adverse____ reactions

- Some patients cannot take a drug due to ____interactions________ with another drug

MTHFR genetics 

- Considerable evidence of folic acid and diseases like depression, bipolar disorder

- MTHFR gene mutations = can’t convert folate to biologically active form Methylfolate

- Methylfolate essential for making ___neurotransmitters___________ serotonin & dopamine

- This can both cause depression AND cause you to be resistant to antidepressive treatments

- No Methylfolate = cannot add methyl___ groups

- Due to SNP in one of two areas of MTHFR gene (50% of population has at least 1 SNP)

- The more SNPs mean the greater it :

- Reduces response to antidepressants

- Reduces response to chemotherapy

- Increases adverse reactions to nitrous oxide (dental anesthesia)

Terms 

- pharmogenetics_____________ = study of the roles of specific genes in drug interactions

- ___charmogenetics______________ = uses genome - wide studies to study drug interactions

- ___pharmokinetics_______________ = studies absorption, activation, metabolism, excretion of drugs ( what the body does to the drug)

- ____pharmodynamics______________ = studies the actual target response (what the drug does to the body)

How genetics play a role in medical drugs

- Genetic factors are all part of the different pharmacy + genetics field

- 1) ___absorption_________ = differences in how patients differ in ability to transport an oral drug to

bloodstream

- 2) ___acrivation_________ = drugs that are given in the form of a prodrug that have to undergo

enzymatic reactions (by the liver) to become active

- 3)____target response____________= differences in how patients process or pathway that is targeted by

the drug response due to local concentration

- 4) _____catobolism and secretion_________________= differences in how patients break down & dispose of the

drug (slow metabolizers have longer/stronger response to drug that fast metabolizers)

- Adverse drug reaction in US = 100,000 deaths/year

- Wasted time in treatment, wasted money, extra suffering

How drugs are metabolized & genetics

- Phase 1 reactions = produce the ____biologically active_______________ molecule

- Polymorphic variations in enzymes among people alter these reactions

- CYP2D6 enzyme= used in metabolism of 25% of all drugs

- poor, intermediate, extensive, ultra rapid metabolizers

- poor = codeine is ineffective______

- ultra rapid = codeine has ____increased risk_________of sedation/impaired breathing

- also linked to beta blockers for hypertension & antidepressants

How drugs are metabolized & genetics 

- Phase 2 reactions = produce water soluble molecule for ___excertion________

- Polymorphic variations in enzymes among people alter these reactions

- Thiopurine methyltransferase (TPMT):

-transfers methyl group to immunosuppressant drug azathioprine

- ___heterozygotes___________ = normal elimination of the drug

- ___homozygotes___________ = life threatening bone marrow toxicity due to poor elimination

Where pharmaceutical companies come in 

- Want to make $ by selling drug to widest possible range of patients: Pharmaceutical genetic medicine: 15 years, $1 billion

- Merk 2004 Vioxx anti-inflammatory for arthritis increased heart attack/stroke

- Stages of development:

- ___preclinical__________= lab studies in vitro & animal = explores toxicity & pharmacokinetics

- _____microdosing__________ = single small dose given to 10 - 15 healthy volunteers (first to involve people)

- explores preliminary pharmacodynamics & pharmacokinetics

- Phase 1 = 100 healthy volunteers

- explores general safety, tolerability, goal how to _____deliver_____ (pill, injection, etc ) & what is the highest dose

- Phase 2 = 100’s of patients

- explores general safety, tolerability , survival time, _____quaility of life_________

- Phase 3 = 1000’s multi - centers & Worldwide, randomized 10,000+ patients Assigned to 2 groups: 1) current treatment vs 2) new treatment ___double blind__________ so participant & research team don’t know who gets what treatment Last step before ___FDA approval_______

- Phase 4 = Post market _____surveillance___________ (largest group: 100,000+ patients)

- explores adverse reactions, long term health implications & off label uses

Genetic medicine - treatment - pharmacogenetics 

- Typically work in 1 of 3 ways

- 1. Enzyme ___replacment_________ therapy = recombinant human enzyme infused to

- compensate for deficient enzyme (LSD – no enzyme to breakdown, must infuse, $500,000 year)

- 2. Substrate reduction_______therapy = oral drug that reduces the level of substrate so that the enzyme works more efficiently

- 3. Pharmacological ___chaperone_________therapy = oral drug that binds misfolded protein so that the protein function is restored

- Lysosomal storage disease example (Gaucher disease)

- Antibiotics (aminoglycosides) – works on bacteria by shutting down ____protein synthesis__________ , but also affect nonsense mutation____________ in humans by distorting the ribosome so that protein synthesis to continue. Currently, about 12%_ of all mutations are nonsense

A closer look at cystic fibrosis & treatment based on genotype 

- CFTR gene

- 2000 known mutation

- F508___deletion

-  90% of CF patients (27,000)

- October 2019 FDA approved Trikafta 

Expression profile of tumors & treatment 

- Traditional approach classify stage________:

- tumor size

- involvement of lymph nodes

- presence of metastases

- Personalized medicine approach _____gene expression_________:

-  Microarray to analyze tumor RNA

-  Identify genes that are up/downregulated

- + stage cancer (early vs late)

- + good or poor survival outcome

- + treatment tailoring

Success of personalized medicine: biomarkers 

- predisposition __________ biomarkers = genetic susceptibility.

- How likely is a person is going to develop a health disorder if they have a certain biomarker.

- Example: BRCA1&2 indicates an increased susceptibility to breast cancer (family history)

- Guides persons future medical care

- diagnostic________ Biomarkers = genetic confirmation.

- Does a patient have a certain disorder.

- Example: CFTR. Presence of mutation would indicate someone has cystic fibrosis.

- Earlier detection than physical examination or symptoms

- prognostic_______ Biomarkers = Genetic progression.

- How a disease may develop in an individual when they have been diagnosed.

- Oncotyping looks at 21 genes to determine likelihood breast cancer will come after initial treatment

- ___predicitve _______ Biomarkers = Genetic treatment.

- Helps to determine what treatments will work best in a particular patient with the least side effects

Other examples of personalized medicine - the need to screen for genetics 

- HIV – Abacavir is a highly effective treatment for HIV, but 8% of patients suffer severe side effects.

- HLA - B 5701 gene variant causes ___hypersensitivity______________to the drug

- Can now screen patients for the variant & give an alternate treatment

- Rheumatoid arthritis – Azathioprine is an immunosuppressant used

- Some patients can’t break down drug, builds up in bone marrow killing immune cells____

- Variant of TPMT gene causes this, can now screen patients for the variant

- Pulmonary embolisms – Warfarin given to reduce blood clots______

- Must give at correct dose = too little no effect (blood clots), too much excess bleeding

- VKORC1 gene variation affects a patient’s sensitivity to Warfarin

Hurdles to personalized medicine 

- Regulatory oversite – FDA So far there is a lack of standards that have not been addressed

- Intellectual property rights US Supreme Court – naturally occurring genes cannot be patented

- Reimbursement How & when to be charged, who pays

- Privacy & confidentiality

- Availability of tests Right now, so many conditions do not have an approved test

-  No current bedside test